Sulfuric Acid

Sulfuric Acid

SCHEMBL1746285

CCN(CC)CC.O=S(=O)([O-])O.[H+]

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CYP51cyp51Acyp51c

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
TSHR P16473 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.38
SIGMAR1 Q99720 1/20 0.31
LMNA P02545 1/20 0.30
HTT P42858 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
CHRM2 P08172 1/20 0.30
CHRM4 P08173 1/20 0.30
CHRM5 P08912 1/20 0.30
CHRM1 P11229 1/20 0.30
CHRM3 P20309 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL11137352 0.84 NPSR1 (0.46) MEN1ALDH1A1KMT2ANPSR1HTT
Sulfuric Acid SCHEMBL78884 0.84 NPSR1 (0.46) MEN1ALDH1A1KMT2ANPSR1HTT
Sulfuric Acid SCHEMBL16059228 0.84 NPSR1 (0.46) MEN1ALDH1A1KMT2ANPSR1HTT
Sulfuric Acid SCHEMBL29289482 0.84 NPSR1 (0.46) MEN1ALDH1A1KMT2ANPSR1HTT
Sulfuric Acid SCHEMBL11137355 0.84 NPSR1 (0.46) MEN1ALDH1A1KMT2ANPSR1HTT
Sulfuric Acid SCHEMBL1334876 0.84 NPSR1 (0.46) MEN1ALDH1A1KMT2ANPSR1HTT
Sulfuric Acid SCHEMBL27883463 0.84 NPSR1 (0.46) MEN1ALDH1A1KMT2ANPSR1HTT
SCHEMBL746207 0.81 NPSR1 (0.40) MEN1ALDH1A1KMT2ANPSR1SIGMAR1
Sulfuric Acid SCHEMBL28536745 0.81 NPSR1 (0.45) MEN1ALDH1A1KMT2ANPSR1CHRM2
Sulfuric Acid SCHEMBL11513250 0.81 NPSR1 (0.45) MEN1ALDH1A1KMT2ANPSR1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025262501-A2 METHOD FOR MANUFACTURING POLYVINYL CHLORIDE PRODUCTS UNILIN, BV (BE) 2025-12-26 WO claimed
US-20250347033-A1 METHOD FOR MAKING FIBRES IMPERIAL COLLEGE INNOVATIONS LTD (GB) 2025-11-13 US claimed
EP-4638574-A1 METHOD FOR MANUFACTURING A POLYVINYL CHLORIDE PRODUCTS Unilin, BV (BE) 2025-10-29 EP claimed
US-20250283255-A1 METHOD FOR MAKING FIBRES IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2025-09-11 US claimed
EP-3822259-B1 METHOD FOR SYNTHESIZING VALSARTAN ZHEJIANG HUAHAI PHARM CO LTD (CN) 2025-08-27 EP claimed
EP-4590410-A1 METHOD FOR RECYCLING POLYVINYL CHLORIDE PRODUCTS Unilin, BV (BE) 2025-07-30 EP claimed
EP-4532808-A1 METHOD FOR MAKING FIBRES Imperial College Innovations Limited (GB) 2025-04-09 EP claimed
EP-4532807-A2 METHOD FOR MAKING FIBRES Imperial College Innovations Limited (GB) 2025-04-09 EP claimed
WO-2025058608-A1 A SUPERCAPACITOR PRODUCTION METHOD DERIVED ENTIRELY FROM WASTE FABRIC T.C. ANKARA UNIVERSITESI REKTORLUGU (TR) 2025-03-20 WO claimed
WO-2024134371-A1 METHOD FOR MANUFACTURING A POLYVINYL CHLORIDE PRODUCTS UNILIN, BV (BE) 2024-06-27 WO claimed
US-20160040354-A1 Treatment IMPERIAL INNOVATIONS LIMITED (GB) 2016-02-11 US claimed
EP-2971333-A1 TREATMENT Imperial Innovations Ltd (GB) 2016-01-20 EP claimed
WO-2014140643-A1 TREATMENT IMPERIAL INNOVATIONS LIMITED (GB) 2014-09-18 WO claimed
EP-2450412-A1 Silicone coating composition AZ Electronic Materials USA Corp. (US) 2012-05-09 EP claimed
EP-2121857-A1 SILICONE COATING COMPOSITION AZ Electronic Materials USA Corp. (US) 2009-11-25 EP claimed
WO-2008102256-A1 SILICONE COATING COMPOSITION AZ ELECTRONIC MATERIALS USA CORP. (DE) 2008-08-28 WO claimed
US-20080196626-A1 High silicon-content resin composition used to form thin film thermosets; form low k dielectric constant materials; hard mask and underlayer materials with anti-reflective properties for photolithography industry MERCK PATENT GMBH (DE) 2008-08-21 US claimed
WO-2000016902-A1 IONIC LIQUIDS BP CHEMICALS LIMITED (GB) 2000-03-30 WO claimed
US-4076949-A REACTING ALCOHOL WITH CARBON MONOXIDE AND OXYGEN, CATALYSIS ATLANTIC RICHFIELD COMPANY (US) 1978-02-28 US claimed
US-4069388-A Preparation of oxalate esters from carbon monoxide and an alkoxycycloalkene ATLANTIC RICHFIELD COMPANY (US) 1978-01-17 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160040354-A1 Treatment DCXR, LCT, MGAM MEN1 4811/4885ALDH1A1 551/4885TSHR 4725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.